Eliot Charles
Presidente presso MiroBio Ltd.
Profilo
Eliot is a Venture Partner based in our London office, concentrating on early-stage investments and new company formation.
He has held prominent roles in leading companies in the healthcare industry and has a successful track record of venture investing and creating new companies.
Eliot started his career at Genentech in business development and later, ran the External R&D Affairs group at Amgen.
While at other venture firms in the Bay area, he was involved in the formation of several new companies, including Affymax (AFFY) and Convergence, and joined another, Principia Biopharma (PRNB), as COO.
Since moving to the UK, Eliot helped found MiroBio, a start-up out of Oxford University, and is actively working with other SR One portfolio companies as well as looking to create new ones.
SR One Companies:
MiroBio, Xap Therapeutics
Education:
Eliot has a BS and MS from the University of Illinois and a PhD in Systems Neuroscience from MIT, where he was a Whittaker Fellow.
Following a post-doctoral fellowship from the Baylor College of Medicine, Eliot received an MBA from the University of Chicago.
Posizioni attive di Eliot Charles
| Società | Posizione | Inizio |
|---|---|---|
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Presidente | 01/01/2019 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investitore di Private Equity | 01/01/2019 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Direttore/Membro del Consiglio | 01/01/2020 |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investitore di Private Equity | 01/01/2013 |
Precedenti posizioni note di Eliot Charles
| Società | Posizione | Fine |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Direttore operativo | 01/06/2012 |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investitore di Private Equity | 01/02/2011 |
| AMGEN INC. | Investitore di Private Equity | 01/08/2009 |
Apax Partners LLP
 Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Investitore di Private Equity | 01/01/2006 |
Genentech USA, Inc.
 Genentech USA, Inc. BiotechnologyHealth Technology Part of Roche Holding AG, Genentech USA, Inc. is an American company dedicated to investigating diverse biological pathways and disease targets in the field of cancer research. The company provides cancer information and resources, as well as explore new research in cancer. | Direttore/Membro del Consiglio | 31/12/2000 |
Formazione di Eliot Charles
| The University of Chicago Booth School of Business | Masters Business Admin |
| University of Illinois At Urbana–Champaign | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Aziende private | 8 |
|---|---|
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Finance |
Apax Partners LLP
Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Finance |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Finance |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Finance |
Genentech USA, Inc.
Genentech USA, Inc. BiotechnologyHealth Technology Part of Roche Holding AG, Genentech USA, Inc. is an American company dedicated to investigating diverse biological pathways and disease targets in the field of cancer research. The company provides cancer information and resources, as well as explore new research in cancer. | Health Technology |
- Borsa valori
- Insiders
- Eliot Charles
